2927
AFC-HD AMS Life Science Co.,Ltd.
ＡＦＣ－ＨＤアムスライフサイエンス
- Industry
- Foods
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Aug 2021
22,368,076
Aug 2022
22,997,127
Aug 2023
25,579,009
Aug 2024
30,185,451
Aug 2025
32,655,022
Operating profit(thousand JPY)
Aug 2021
2,245,239
Aug 2022
1,011,147
Aug 2023
1,636,285
Aug 2024
1,916,188
Aug 2025
2,409,620
Operating profit margin(%)
Aug 2021
10.04
Aug 2022
4.4
Aug 2023
6.4
Aug 2024
6.35
Aug 2025
7.38
Profit before tax(thousand JPY)
Aug 2021
2,157,807
Aug 2022
1,235,439
Aug 2023
1,545,969
Aug 2024
1,910,802
Aug 2025
2,200,999
Profit(thousand JPY)
Aug 2021
1,495,554
Aug 2022
735,353
Aug 2023
1,102,563
Aug 2024
1,252,067
Aug 2025
1,448,545
Total assets(thousand JPY)
Aug 2021
35,752,403
Aug 2022
37,348,660
Aug 2023
41,071,748
Aug 2024
47,030,684
Aug 2025
48,726,913
Cash and cash equivalents(thousand JPY)
Aug 2021
8,667,136
Aug 2022
10,257,778
Aug 2023
11,062,021
Aug 2024
12,070,550
Aug 2025
11,199,882
Cash flows from operating activities(thousand JPY)
Aug 2021
2,582,697
Aug 2022
1,492,417
Aug 2023
865,280
Aug 2024
1,540,093
Aug 2025
1,786,827
Cash flows from investing activities(thousand JPY)
Aug 2021
-274,967
Aug 2022
-1,077,917
Aug 2023
-1,946,009
Aug 2024
-2,761,467
Aug 2025
-3,326,986
Cash flows from financing activities(thousand JPY)
Aug 2021
2,185,303
Aug 2022
1,159,612
Aug 2023
1,881,171
Aug 2024
2,232,074
Aug 2025
666,749
Return on equity(%)
Aug 2021
13.4
Aug 2022
6.1
Aug 2023
8.6
Aug 2024
9.3
Aug 2025
10
Equity ratio(%)
Aug 2021
33.1
Aug 2022
33.2
Aug 2023
31.9
Aug 2024
29.6
Aug 2025
30.9
Earnings per share(JPY per share)
Aug 2021
107.12
Aug 2022
52.33
Aug 2023
78.51
Aug 2024
89.2
Aug 2025
102.98
Net assets per share(JPY per share)
Aug 2021
833.44
Aug 2022
884.53
Aug 2023
938.25
Aug 2024
990.1
Aug 2025
1,069.89
Dividend per share(JPY per share)
Aug 2021
27.5
Aug 2022
30
Aug 2023
27.5
Aug 2024
30
Aug 2025
34
Payout ratio(%)
Aug 2021
25.67
Aug 2022
57.33
Aug 2023
35.03
Aug 2024
33.63
Aug 2025
33.02
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.